CEG surges 13% as Wikipedia attention hits new high

Options positioning has turned more defensive in the wake of that move. The put/call ratio came in at 1.68 on Tuesday, above its 20-day average of 1.53, and touched a 52-week high of 1.76 on Monday, the session immediately following the big gap. The z-score of 1.16 is elevated but not extreme, suggesting hedging demand rather than outright panic. Notably, the PCR had been trending upward since mid-September, before the spike, which means some protection was already in place ahead of the catalyst. In the lending market, conditions tell a different story: availability is very loose at over 1,600%, meaning there are more than 16 shares available to borrow for every one already shorted. Borrowing costs are minimal at 0.42%, roughly flat on the week. Short interest at 3.8% of free float is modest and has barely moved, up just 0.2% on the week despite rising 27% over the past month. There is no squeeze dynamic here.

The Street is broadly constructive, though targets tell a nuanced story. The consensus leans bullish, with most recent ratings at Overweight or Buy. Morgan Stanley raised its target to $369 in mid-September, a few weeks before the stock re-rated. But the mean analyst target sits at $341.53, which implies further upside from $300 but also shows the stock has already recaptured much of the distance to consensus. Goldman Sachs and Citigroup both hold Neutral ratings with targets around $297 to $305, now fractionally below where the stock trades. The valuation has moved sharply: the P/E expanded by 3.5 turns over the past week to 23.0x, and EV/EBITDA rose by 1.2 turns to 12.2x. Factor scores give some texture to the longer-term debate. Forward earnings growth ranks in the 74th percentile, and the dividend score ranks in the 97th percentile, suggesting durable income and growth credentials. EPS surprise ranks only in the 27th percentile, a reminder that the stock has historically not beaten forecasts as reliably as the bull case might imply.

The bull case centres on the company's nuclear generation portfolio and a path for EPS to climb from $12.75 in 2027 to $16.43 by 2030, driven by commodity price tailwinds and the roll-off of below-market nuclear production tax credit pricing. Bears point to regulatory uncertainty, rising operational costs, and the risk that hyperscalers retreat from data-centre power offtake deals that have underpinned some of the premium valuation. The activist register carries no Schedule 13D filers, and all major 13G holders are passive. ECP ControlCo, an energy-focused private equity vehicle, trimmed from 6.1% to 4.0% in its most recent disclosure filed in August, though stakes are as-last-disclosed around the 5% threshold and may not reflect current positioning. The one insider open-market purchase in the last 90 days came from a director, Roger Crandall, who bought 1,500 shares at $278.62 in August for roughly $418,000, a signal of conviction at lower prices.

With earnings 29 days away on November 5, the key question is whether this week's price move was a re-rating on new information or a technically driven gap that leaves the stock exposed to a give-back. The next print will test whether operating results are keeping pace with the valuation expansion the market has just delivered.